Skip to content
  • Thursday, 9 July 2026
  • 5:10 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership
Pharmaceutical R&D

Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership

Teuku Ryan May 21, 2026 0

Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…

Read More
First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?Human Lungs Identified as a Vital Site for Blood Production and Stem Cell ReservoirJAMA study finds moderate caffeine intake tracks with lower dementia risk, provides adenosine-pathway nudge for drug huntersPrecision Synthesis Method Unlocks Unprecedented Performance in MXene Nanomaterials through Surface Engineering
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information Stability
Scientists develop new bone marrow imaging techniqueThe biotech bi-weekly: a disease modeling research grant and an accelerator program for data-driven health start-upsWhat if psilocybin works about as well for depression as an SSRI?Bridging the Gap Between Neuroscience and Psychoanalysis How Modern Brain Models Echo Freudian Theory
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Scientists develop new bone marrow imaging technique
Dwi Wanna Jul 9, 2026
Biotech & Genetic Research
The biotech bi-weekly: a disease modeling research grant and an accelerator program for data-driven health start-ups
Jia Lissa Jul 9, 2026
Laboratory Automation & Robotics
What if psilocybin works about as well for depression as an SSRI?
Lana Keisha Jul 9, 2026
Neuroscience & Brain Research
Bridging the Gap Between Neuroscience and Psychoanalysis How Modern Brain Models Echo Freudian Theory
Rifan Muazin Jul 9, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ